These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
316 related items for PubMed ID: 24254306
1. Promoter hypermethylation of p14 (ARF) , RB, and INK4 gene family in hepatocellular carcinoma with hepatitis B virus infection. Zhang JC, Gao B, Yu ZT, Liu XB, Lu J, Xie F, Luo HJ, Li HP. Tumour Biol; 2014 Mar; 35(3):2795-802. PubMed ID: 24254306 [Abstract] [Full Text] [Related]
2. Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma. Roncalli M, Bianchi P, Bruni B, Laghi L, Destro A, Di Gioia S, Gennari L, Tommasini M, Malesci A, Coggi G. Hepatology; 2002 Aug; 36(2):427-32. PubMed ID: 12143052 [Abstract] [Full Text] [Related]
3. Differential DNA methylation associated with hepatitis B virus infection in hepatocellular carcinoma. Su PF, Lee TC, Lin PJ, Lee PH, Jeng YM, Chen CH, Liang JD, Chiou LL, Huang GT, Lee HS. Int J Cancer; 2007 Sep 15; 121(6):1257-64. PubMed ID: 17534893 [Abstract] [Full Text] [Related]
4. p16 is a major inactivation target in hepatocellular carcinoma. Jin M, Piao Z, Kim NG, Park C, Shin EC, Park JH, Jung HJ, Kim CG, Kim H. Cancer; 2000 Jul 01; 89(1):60-8. PubMed ID: 10897001 [Abstract] [Full Text] [Related]
5. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas. Tannapfel A, Busse C, Weinans L, Benicke M, Katalinic A, Geissler F, Hauss J, Wittekind C. Oncogene; 2001 Oct 25; 20(48):7104-9. PubMed ID: 11704835 [Abstract] [Full Text] [Related]
6. Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma. Chinnasri P, Pairojkul C, Jearanaikoon P, Sripa B, Bhudhisawasdi V, Tantimavanich S, Limpaiboon T. Hum Pathol; 2009 Jun 25; 40(6):817-26. PubMed ID: 19200577 [Abstract] [Full Text] [Related]
7. Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors. Endo M, Kobayashi C, Setsu N, Takahashi Y, Kohashi K, Yamamoto H, Tamiya S, Matsuda S, Iwamoto Y, Tsuneyoshi M, Oda Y. Clin Cancer Res; 2011 Jun 01; 17(11):3771-82. PubMed ID: 21262917 [Abstract] [Full Text] [Related]
8. Alteration of the p14(ARF) gene and p53 status in human hepatocellular carcinomas. Ito T, Nishida N, Fukuda Y, Nishimura T, Komeda T, Nakao K. J Gastroenterol; 2004 Jun 01; 39(4):355-61. PubMed ID: 15168247 [Abstract] [Full Text] [Related]
9. The prognostic significance of p16(INK4a)/p14(ARF) locus deletion and MDM-2 protein expression in adult acute myelogenous leukemia. Faderl S, Kantarjian HM, Estey E, Manshouri T, Chan CY, Rahman Elsaied A, Kornblau SM, Cortes J, Thomas DA, Pierce S, Keating MJ, Estrov Z, Albitar M. Cancer; 2000 Nov 01; 89(9):1976-82. PubMed ID: 11064355 [Abstract] [Full Text] [Related]
10. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course. Watanabe T, Katayama Y, Yoshino A, Komine C, Yokoyama T. Clin Cancer Res; 2003 Oct 15; 9(13):4884-90. PubMed ID: 14581362 [Abstract] [Full Text] [Related]
11. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma. Peng CY, Chen TC, Hung SP, Chen MF, Yeh CT, Tsai SL, Chu CM, Liaw YF. Anticancer Res; 2002 Oct 15; 22(2B):1265-71. PubMed ID: 12168936 [Abstract] [Full Text] [Related]
12. Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis. Edamoto Y, Hara A, Biernat W, Terracciano L, Cathomas G, Riehle HM, Matsuda M, Fujii H, Scoazec JY, Ohgaki H. Int J Cancer; 2003 Sep 01; 106(3):334-41. PubMed ID: 12845670 [Abstract] [Full Text] [Related]
13. Aberrant methylation of p14(ARF), p15(INK4b) and p16(INK4a) genes and location of the primary site in pulmonary squamous cell carcinoma. Furonaka O, Takeshima Y, Awaya H, Ishida H, Kohno N, Inai K. Pathol Int; 2004 Aug 01; 54(8):549-55. PubMed ID: 15260845 [Abstract] [Full Text] [Related]
14. p16(INK4a) and p15(INK4b) gene promoter methylation in cervical cancer patients. Jha AK, Nikbakht M, Jain V, Capalash N, Kaur J. Oncol Lett; 2012 Jun 01; 3(6):1331-1335. PubMed ID: 22783444 [Abstract] [Full Text] [Related]
15. Alterations of p14 ARF , p15 INK4b , and p16 INK4a Genes in Primary Laryngeal Squamous Cell Carcinoma. López F, Sampedro T, Llorente JL, Hermsen M, Álvarez-Marcos C. Pathol Oncol Res; 2017 Jan 01; 23(1):63-71. PubMed ID: 27377733 [Abstract] [Full Text] [Related]
16. Promoter hypermethylation profile of cell cycle regulator genes in pituitary adenomas. Yoshino A, Katayama Y, Ogino A, Watanabe T, Yachi K, Ohta T, Komine C, Yokoyama T, Fukushima T. J Neurooncol; 2007 Jun 01; 83(2):153-62. PubMed ID: 17216555 [Abstract] [Full Text] [Related]
17. Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation status. Chaussade L, Eymin B, Brambilla E, Gazzeri S. Oncogene; 2001 Oct 04; 20(45):6587-96. PubMed ID: 11641784 [Abstract] [Full Text] [Related]
18. Methylation, expression, and mutation analysis of the cell cycle control genes in human brain tumors. Yin D, Xie D, Hofmann WK, Miller CW, Black KL, Koeffler HP. Oncogene; 2002 Nov 28; 21(54):8372-8. PubMed ID: 12447702 [Abstract] [Full Text] [Related]
19. Association of p16INK4A hypermethylation with hepatitis B virus X protein expression in the early stage of HBV-associated hepatocarcinogenesis. Zhu R, Li BZ, Li H, Ling YQ, Hu XQ, Zhai WR, Zhu HG. Pathol Int; 2007 Jun 28; 57(6):328-36. PubMed ID: 17539963 [Abstract] [Full Text] [Related]
20. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque. Holdt LM, Sass K, Gäbel G, Bergert H, Thiery J, Teupser D. Atherosclerosis; 2011 Feb 28; 214(2):264-70. PubMed ID: 20637465 [Abstract] [Full Text] [Related] Page: [Next] [New Search]